CSIMarket
 


Biodelivery Sciences International Inc   (BDSI)
Other Ticker:  
 


Biodelivery Sciences International Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biodelivery Sciences International Inc's ROI in the fourth quarter of 2021?
Biodelivery Sciences International Inc achieved a return on average invested assets (ROI) of 42.72 % in its fourth quarter of 2021 a new company high.

ROI has improved compared to 16.86% in the third quarter of 2021, due to net income growth.

Within the Healthcare sector 30 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2021 quarter, so far to 137, from total ROI ranking in the third quarter of 2021 at 369.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Investment Change 29.6 % 2.21 % 14.07 % 38.22 % -
Y / Y Net Income Change 526.56 % -28.92 % 678.03 % 5.46 % -
Investment (TTM) in Millions 242 178 186 188 187
Return On Investment (TTM) 42.72 % 16.86 % 18.43 % 14.59 % 15.57 %
BDSI's Overall Ranking # 137 # 369 # 270 # 240 # 189
Seq. Investment Change 35.76 % -4.3 % -0.6 % 0.35 % 7.08 %
Seq. Net Income Change 858.01 % -26.42 % 73.08 % -48.64 % 8.68 %
Net Income (TTM) in Millions 85 31 34 26 26




Return On Investment BDSI's Ranking
Within: No.
Industry # 15
Sector # 31
Overall # 137

Return On Investment Statistics
High Average Low
42.72 %
-57.6 %
-274.09 %
(Dec 31 2021)   (Dec. 30, 2013)







Financial Statements
Biodelivery Sciences International Inc's IV. Quarter Investments $ 242 Millions BDSI's Balance sheet
Biodelivery Sciences International Inc's IV. Quarter Income $ 64 Millions Quarterly BDSI's Income Statement
BDSI's Income by Division See BDSI's Income by Division


BDSI Annual Return On Investment (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Investments in Millions 242 187 129 87 62
Y / Y Investment Growth 29.6 % 44.98 % 48.18 % 40.42 % 91.02 %
Net Income in Millions 85 26 -15 -34 5
Y / Y Net Income Growth 230.05 % - - - -
Annual Return On Investment 35.03 % 13.76 % -11.87 % -38.93 % 8.53 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 35.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDSI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for BDSI's Competitors
Roi for Biodelivery Sciences International Inc's Suppliers
Return On Investment for BDSI's Customers

Other Ratios
BDSI's Roa BDSI's Inventory Turnover Ratio BDSI's Growth Rates BDSI's Dividend Statistics
BDSI's Profitability Ratios BDSI's Asset Turnover Ratio BDSI's Dividend Growth
BDSI's Roe BDSI's Valuation Ratios BDSI's Financial Strength Ratios BDSI's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Omeros Corp  117.05 %
Galmed Pharmaceuticals Ltd   106.46 %
Redhill Biopharma Ltd   100.18 %
Vyne Therapeutics Inc   93.73 %
Agios Pharmaceuticals Inc   90.82 %
Biontech Se  83.35 %
Meihua International Medical Technologies Co Ltd   77.76 %
Sinovac Biotech Ltd  76.57 %
Dariohealth Corp   74.73 %
Alpha Tau Medical Ltd   72.13 %
Scisparc Ltd   70.95 %
Ovid Therapeutics Inc   59.58 %
Glucotrack Inc   58.06 %
Biomx Inc   57.30 %
Vascular Biogenics Ltd   57.14 %
Halozyme Therapeutics Inc   56.19 %
Iteos Therapeutics Inc   54.32 %
Fulgent Genetics Inc   50.82 %
Uniqure N v   50.06 %
Siga Technologies Inc  49.80 %
Vir Biotechnology Inc   49.45 %
Molecular Templates inc   48.02 %
Reflect Scientific Inc   47.91 %
Integrated Biopharma Inc  46.85 %
Regeneron Pharmaceuticals Inc   43.91 %
Biodelivery Sciences International Inc   42.72 %
Idexx Laboratories Inc  41.83 %
Semler Scientific Inc   41.56 %
Inmode Ltd   39.24 %
Quidelortho Corp  37.03 %


Date modified: 2023-03-23T19:06:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com